Technology | Computer-Aided Detection Software | March 27, 2017

iCAD Receives FDA Approval for PowerLook Tomo Detection

Deep learning technology improves efficiency and reduces reading time on digital breast 3-D tomosynthesis for radiologists

iCAD, PowerLook Tomo Detection, computer-aided detection software, CAD, digital breast tomosynthesis, DBT, RSNA 2017

March 27, 2017 — iCAD announced that PowerLook Tomo Detection received Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA). PowerLook Tomo Detection is a concurrent-read computer-aided detection (CAD) solution for digital breast 3-D tomosynthesis, available on the PowerLook Breast Health Solutions platform. 

Two-dimensional digital mammography typically produces four images per exam while digital breast 3-D tomosynthesis can produce hundreds of images, significantly increasing exam interpretation time for radiologists. PowerLook Tomo Detection improves radiologists’ efficiency by automatically analyzing each tomosynthesis plane and identifying suspicious areas. The suspicious areas are naturally blended onto a 2-D synthetic image to provide radiologists with a single enhanced image that is used to more efficiently navigate the large tomosynthesis data set. 

“iCAD has taken a refreshing new approach to computer-aided detection. This innovative workflow solution detects suspicious areas on the tomosynthesis planes and that information is used to deliver an enhanced image that focuses the radiologist on the specific areas that need further investigation,” said Justin Boatsman, M.D., medical director and diagnostic radiologist, Intrinsic Imaging LLC, who took part in the U.S. clinical study. “This not only helps reduce the reading time and improve the reading experience for radiologists, but it can also provide radiologists with an added level of confidence.” 

In a U.S., clinical study conducted from October 2015 to January 2016, radiologists were able to significantly reduce reading time when reading 3-D tomosynthesis exams with PowerLook Tomo Detection. The study included 20 radiologists reading 240 tomosynthesis cases, both with and without the PowerLook Tomo Detection technology. Reading time was reduced by up to 37 percent with an average reduction of 29 percent when using PowerLook Tomo Detection, with no statistically significant impact on sensitivity, specificity or recall rate.

Another European clinical study was completed with six radiologists reading 80 cases and showed similar results and was the basis for CE Mark of PowerLook Tomo Detection in April 2016. 

The application employs deep learning, a branch of machine learning that uses sophisticated algorithms that are trained to recognize the visual characteristics of a cancer by analyzing actual patient images. The current version of the algorithm was trained using thousands of images. 

PowerLook Tomo Detection, currently available on GE Healthcare digital breast tomosynthesis systems, also received CE Mark and Health Canada approval in 2016, and is currently being used by multiple high volume breast imaging centers in Europe.

For more information: www.icadmed.com

Related Content

QView Medical Showcases QVCAD for ABUS Exams at RSNA 2018
News | Ultrasound Women's Health | November 19, 2018
QView Medical will showcase QVCAD, the first U.S. Food and Drug Administration (FDA)-approved artificial intelligence (...
Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
Breast Density Advocate Nancy M. Cappello Passes Away

Nancy Cappello. Image courtesy of AreYouDense.org.

News | Breast Density | November 15, 2018 | Jeff Zagoudis, Associate Editor
Imaging Technology News extends its condolences to the family, friends and colleagues of Nancy M. Cappello, Ph.D., who...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
Feature | Breast Imaging | November 07, 2018 | By Jeff Zagoudis
Breast imaging technology has experienced major growth over the last decade or so, and a new report suggests the mark
Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing  information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Feature | Breast Imaging | November 05, 2018 | By Jeff Zagoudis
The incidence of breast cancer is rising globally, with an estimated 1 in 8 women diagnosed in their lifetime and 40,...
Deaconess Health System Chooses Sectra as Enterprise Imaging Vendor
News | Enterprise Imaging | November 02, 2018
International medical imaging information technology (IT) and cybersecurity company Sectra will install its enterprise...